title: 4D reconstruction for low-dose cardiac gated SPECT.
abstract: OBJECTIVE
  Due to the combination of high-frequency use and relatively high diagnostic radiation dose (>9 mSv for one scan), there is a need to lower the radiation dose used in myocardial perfusion imaging (MPI) studies in cardiac gated single photon emission computed tomography (GSPECT) in order to reduce its population based cancer risk. The aim of this study is to assess quantitatively the potential utility of advanced 4D reconstruction for GSPECT for significantly lowered imaging dose.
  
  
  METHODS
  For quantitative evaluation, Monte Carlo simulation with the 4D NURBS-based cardiac-torso (NCAT) phantom is used for GSPECT imaging at half and quarter count levels in the projections emulating lower injected activity (dose) levels. Both 4D and 3D reconstruction methods are applied at these lowered dose levels, and compared with standard clinical spatiotemporal reconstruction (ST121) at full dose using a number of metrics on the reconstructed images: (1) overall reconstruction accuracy of the myocardium, (2) regional bias-variance analysis of the left ventricle (LV) wall, (3) uniformity of the LV wall, (4) accuracy of the time activity curve (TAC) of the LV wall, and (5) detectability of perfusion defects using channelized Hotelling observer. As a preliminary demonstration, two sets of patient data acquired in list-mode are used to illustrate the conservation of both image quality and LV ejection fraction (LVEF) by 4D reconstruction where only a portion of the acquired counts at each projection angle are used to mimic low-dose acquisitions.
  
  
  RESULTS
  Compared to ST121 at standard dose, even at quarter dose 4D achieved better performance on overall reconstruction accuracy of the myocardium (28.7% improvement on relative root mean square error: standard vs 4D quarter p-value < 10(-30)), regional bias-variance analysis, and similar performance on accuracy of the TAC of the LV wall and detectability of perfusion defects. A slight degradation in uniformity of the LV wall was observed in 4D at quarter dose due to use of scatter correction which increases reconstruction variance. The reconstructed images from simulated and patient data show that 4D at quarter dose is visually comparable to ST121 at standard dose, if not better. Compared to ST121 and 3D, 4D images exhibit less noise artifacts and better definition of the LV wall. The 4D images are also observed to be more consistent between half dose and quarter dose. 4D also yields more consistent LVEF results at different count levels on the patient data.
  
  
  CONCLUSIONS
  With various quantitative metrics 4D reconstruction is demonstrated to achieve better or comparable performance at quarter dose (∼2.25 mSv, 75% dose reduction) compared to conventional clinical reconstruction at standard dose (∼9 mSv). Preliminary results from two patient datasets also show that 4D at an equivalent quarter dose can achieve better performance than clinical and 3D methods at higher dose levels. Such a significant dose reduction (75%) has not been demonstrated quantitatively in previous studies in GSPECT. These promising results warrant further investigations on the lower bound of dose reduction with different reconstruction strategies and more comprehensive clinical studies with greater patient variability.
authors: Department of Physics, University of Texas, Arlington, TX 76019, USA.
authors: Mingwu
authors: M
authors: Jin
authors: Xiaofeng
authors: X
authors: Niu
authors: Wenyuan
authors: W
authors: Qi
authors: Yongyi
authors: Y
authors: Yang
authors: Joyoni
authors: J
authors: Dey
authors: Michael A
authors: MA
authors: King
authors: Seth
authors: S
authors: Dahlberg
authors: Miles N
authors: MN
authors: Wernick
mesh_terms: D000368:Aged; D055426:Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography / Q000379:methods*; D005260:Female; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000473:pathology; D006801:Humans; D021621:Imaging, Three-Dimensional / Q000379:methods*; D008297:Male; D011829:Radiation Dosage
references: Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):750-7
references: 19921186
references: Circulation. 2010 Dec 7;122(23):2403-10
references: 21098448
references: Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):499-508
references: 21069317
references: Comput Methods Programs Biomed. 1989 Aug;29(4):257-72
references: 2791527
references: Health Phys. 2008 Nov;95(5):502-7
references: 18849682
references: Clin Nucl Med. 2012 Jul;37(7):e162-9
references: 22691526
references: IEEE Trans Med Imaging. 1991;10(3):408-12
references: 18222843
references: Phys Med Biol. 2010 Sep 7;55(17):4949-61
references: 20693615
references: J Nucl Med. 1997 Oct;38(10):1528-35
references: 9379187
references: J Nucl Cardiol. 2007 Jul;14(4):555-65
references: 17679065
references: J Nucl Cardiol. 2011 Apr;18(2):273-80
references: 21287370
references: J Nucl Med. 2009 Apr;50(4):554-62
references: 19289436
references: Phys Med Biol. 1998 Apr;43(4):875-86
references: 9572511
references: Phys Med Biol. 2006 Sep 21;51(18):4603-19
references: 16953045
references: Med Phys. 2011 Dec;38(12):6571-84
references: 22149839
references: J Nucl Cardiol. 2005 Mar-Apr;12(2):208-15
references: 15812376
references: Cleve Clin J Med. 2005 Jan;72(1):21-5, 29-33
references: 15691055
references: J Opt Soc Am A. 1987 Dec;4(12):2447-57
references: 3430229
references: CMAJ. 2011 Mar 8;183(4):430-6
references: 21324846
references: IEEE Trans Med Imaging. 2000 May;19(5):423-33
references: 11021686
references: Med Phys. 2005 Sep;32(9):2839-49
references: 16266098
references: Phys Med Biol. 2009 Sep 21;54(18):5643-59
references: 19724094
references: J Nucl Med. 2000 Mar;41(3):502-13
references: 10716326
references: J Nucl Cardiol. 2008 Jul-Aug;15(4):547-63
references: 18674723
references: Radiology. 2009 Apr;251(1):6-12
references: 19332841
references: Radiology. 2009 Apr;251(1):13-22
references: 19332842